Comparative toxicity and antioxidant activity of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its monoamine oxidase B-generated metabolites in isolated hepatocytes and liver microsomes
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 255 (1), 14-18
- https://doi.org/10.1016/0003-9861(87)90289-x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytesBiochemical and Biophysical Research Communications, 1986
- Antioxidants fail to inhibit depletion of striatal dopamine by MPTPNeurology, 1986
- Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicityBiochemical and Biophysical Research Communications, 1986
- Formation of superoxide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion(MPP+): Reductive activation by NADPH cytochrome P-450 reductaseBiochemical and Biophysical Research Communications, 1986
- Ascorbic acid reduces the dopamine depletion induced by MPTPNeuropharmacology, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- ENZYME-STRUCTURE RELATIONSHIPS IN THE ENDOPLASMIC RETICULUM OF RAT LIVERThe Journal of cell biology, 1962